Related Experiment Video
Updated: Jul 5, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Prodrug cancer gene therapy
1Cancer Research Institute, Slovak Academy of Sciences, Vlarska 7, 83391 Bratislava, Slovakia.
Abstract:
There is no effective treatment for late stage and metastatic cancers of colorectal, prostate, pancreatic, breast, glioblastoma and melanoma cancers. Novel treatment modalities are needed for these late stage patients because cytotoxic chemotherapy offers only palliation, usually accompanied with systemic toxicities and poor quality of life. Gene directed enzyme prodrug therapy (GDEPT), which concentrates the cytotoxic effect in the tumor site may be one alternative. This review provides an explanation of the GDEPT principle, focusing on the development, application and potential of various GDEPTs. Current gene therapy limitations are in efficient expression of the therapeutic gene and in tumor-specific targeting. Therefore, the current status of research related to the enhancement of in situ GDEPT delivery and tumor-specific targeting of vectors is assessed. Finally, GDEPT versions of stem cell based gene therapy as another potential treatment modality for progressed tumors and metastases are discussed. Combinations of traditional, targeted, and stem cell directed gene therapy could significantly advance the treatment of cancer.
Insights
Novel gene-directed enzyme prodrug therapy (GDEPT) offers a promising alternative to chemotherapy for advanced cancers. Research focuses on improving gene delivery and targeting for better cancer treatment outcomes.
Area of Science:
- Oncology
- Gene Therapy
- Cancer Treatment
Background:
- Late-stage and metastatic cancers (colorectal, prostate, pancreatic, breast, glioblastoma, melanoma) lack effective treatments.
- Current cytotoxic chemotherapy provides limited palliation with significant toxicities and poor quality of life.
Purpose of the Study:
- To review the principles, development, application, and potential of gene-directed enzyme prodrug therapy (GDEPT).
- To assess current research on enhancing in situ GDEPT delivery and tumor-specific targeting.
- To discuss stem cell-based GDEPT for advanced tumors and metastases.
Main Methods:
- Review of existing literature on GDEPT principles and applications.
- Assessment of research on improving gene therapy delivery and targeting.
- Discussion of stem cell-based gene therapy approaches for cancer.
Main Results:
- GDEPT concentrates cytotoxic effects at the tumor site, potentially overcoming limitations of systemic chemotherapy.
- Enhancing in situ delivery and tumor-specific targeting are key research areas for GDEPT.
- Stem cell-based GDEPT presents a potential modality for treating progressed tumors and metastases.
Conclusions:
- GDEPT represents a promising alternative for treating advanced and metastatic cancers.
- Improvements in gene delivery and tumor targeting are crucial for GDEPT efficacy.
- Combinations of gene therapy approaches, including stem cell-directed methods, could significantly advance cancer treatment.
Related Concept Videos
Gene Therapy
Gene Therapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

